Stocks

Magazine articles on individual stocks, valuation, accounting standards, IPO's, brokerages, exchanges.

Old Articles: <Older 25081-25090 Newer>

The Motley Fool August 1, 2007 Mac Greer	Fool Video: Time to Buy Whole Foods? Better-than-expected earnings, low stock price. Hmmm ... is it time to buy Whole Foods? Video discusses the food retailer.
The Motley Fool August 1, 2007 Brian Lawler	Calling Out Endo Endo Pharmaceuticals gets taken to task by an activist investor. An investment group owning 5.6% of outstanding shares is concerned with how management plans to use $700 million available to them in cash and investments.
The Motley Fool August 1, 2007 Markos Kaminis	Chicken Goes Cha-Ching for Tyson Tyson Foods is benefiting from rising protein prices and cost-cutting measures. Confidence in overseas demand, and minimal resistance to higher prices, led management to raise its fiscal 2007 guidance.
The Motley Fool August 1, 2007 Rich Smith	This Borg Is Too Pretty BorgWarner shares have retreated 8% off their all-time high two weeks ago. Last week's quarterly report was outstanding, and future prospects are excellent for the auto parts producer, but valuation is currently too high.
The Motley Fool August 1, 2007 Rich Smith	Oshkosh on the Open Road Oshkosh Truck, maker of all species of trucks, from fire trucks to cement mixers to armored vehicles, reports higher sales and profits, but optimistic statements regarding MRAP need to be taken with a grain of salt.
The Motley Fool August 1, 2007 Brian Lawler	Elan Gets a Vote of Confidence Elan receives some good news from an FDA advisory panel in the form of a recommendation to expand the use of Tysabri to treat Crohn's disease.
The Motley Fool August 1, 2007 Brian Lawler	Neurocrine Awaits Its Destiny Neurocrine Biosciences updates investors on its plans for the rest of the year. A new marketing application was submitted for lead drug indiplon, following a negative FDA decision last year. Good news could come as soon as December 2007.
The Motley Fool August 1, 2007 Ryan Fuhrmann	Foolish Forecast: CVS Caremark Gets Ready to Rumble CVS Caremark will announce its first combined quarterly results tomorrow. Competitors will be watching to see if the merger of drugstore chain and pharmacy benefit manager is a healthy one.
The Motley Fool August 1, 2007 Rich Smith	LCA-Vision Investors Blindsided Clearly, something was amiss with analyst's forecasts for LCA-Vision. Actual quarterly results for the LASIK specialist were substantially lower than anyone saw coming.
The Motley Fool August 1, 2007 Markos Kaminis	Kellogg: Perfect Play or Played Out? Kellogg offers shareholders steady and sustainable operating growth, thanks to opportunities in international markets, but its shares may offer less, due to their high valuation.
<Older 25081-25090 Newer> Return to current articles.